UrsulaReuschMD

Internal Medicine • Kansas City, KS

Hospital Medicine/Hospitalist, Hematology/Oncology

KC Hospitalists

Join to view full profile

Dr. Reusch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Reusch's full profile

Already have an account?

Office
8929 Parallel Pkwy
Kansas City, KS 66112
Phone+1 913-596-4860

Fax+1 913-596-4635

Education & Training

Brown UniversityFellowship, Hematology and Medical Oncology, 2006
Brown UniversityResidency, Internal Medicine, 2000 - 2003
University of Missouri-Columbia School of MedicineClass of 2000

Certifications & Licensure

MO State Medical License 2016 - 2026
KS State Medical License 2016 - 2025
GA State Medical License 2010 - 2018
RI State Medical License 2001 - 2012
American Board of Internal Medicine Internal Medicine

Publications & Presentations

PubMed

68 citations
Anti-CD3 x anti-epidermal growth factor receptor (EGFR) bispecific antibody redirects T-cell cytolytic activity to EGFR-positive cancers in vitro and in an animal model.
Ursula Reusch, Magesh Sundaram, Pamela A. Davol, Sarah D. Olson, James B. Davis
Clinical Cancer Research. 2006-01-01